About OptimizeRx Corporation - Common Stock (OPRX)
OptimizeRx Corporation is a technology-driven healthcare communications company that specializes in streamlining the prescription process and enhancing patient engagement through its digital platform. The company provides a suite of solutions that connect healthcare providers, patients, and pharmaceutical companies, allowing for the efficient exchange of information related to prescription medications, copay assistance, and adherence programs. By leveraging real-time data and innovative technologies, OptimizeRx aims to improve patient outcomes and facilitate better healthcare experiences while driving value for its partners in the pharmaceutical and healthcare industries. Read More
WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the fourth quarter and full year ended December 31, 2025.
WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the fourth quarter and full year ended December 31, 2025.
Whetstone Capital Advisors has sold its stake in GitLab, a unified DevOps platform competing in the fast-changing market for AI-assisted coding and secure software delivery. As companies look at combining platforms and adding AI, investors are considering whether GitLab will be able to compete in the future of enterprise development.
WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, March 5, 2026, at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter period ended December 31, 2025. The financial results will be issued in a press release prior to the call.
Life science marketers will be able to better measure the exposed audiences for a more complete, accurate, and transparent view of campaign engagement and effectiveness
- Q3 revenue of $26.1 million, increased 22% year-over-year- Q3 gross profit increased 30% year-over-year to $17.5 million- Increases full year 2025 guidance to a revenue range between $105 million and $109 million and adjusted EBITDA range between $16 million and $19 million- Introduces 2026 guidance with a revenue range between $118 million and $124 million and adjusted EBITDA range between $19 million and $22 million- Paid off an incremental $2 million in principal from term loan subsequent to the end of Q3
WALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, November 6, 2025, at 4:30 p.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2025. The financial results will be issued in a press release prior to the call.
Discover how OptimizeRx (OPRX) exemplifies the Minervini Trend Template, combining strong technical momentum with explosive fundamental growth for a powerful stock setup.
UnitedHealth Group (NYSE: UNH), a dominant force in the U.S. healthcare landscape, is currently embroiled in an unprecedented storm of regulatory and legal scrutiny. Federal Justice Department probes targeting its expansive vertical integration and Medicare Advantage billing practices are intensifying, while the company continues to reel from the catastrophic
WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference taking place Thursday, September 11, 2025, in New York, NY.
